Optical coherence tomography reveals that a significant proportion of sirolimus-eluting stents remain incompletely covered by neointima at 6 and 12 months, supporting the rationale for prolonged dual antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
May support extended DAPT caution after sirolimus-eluting stents; leaves open randomized confirmation of coverage-guided duration.
Yao et al. (2008) studied this question.